81 Director Training, Conferences, Seminars, Workshops Attended Lim Tsin-Lin i. Mandatory Accreditation Programme (MAP) Part II – Leading for Impact (LIP) ii. Leading Change and Organization Renewal Program Mehmet Ali Aydinlar i. Mandatory Accreditation Programme (MAP) Part II – Leading for Impact (LIP) Mohd Shahazwan bin Mohd Harris i. SLU: Bumiputera Participation in Public Equities ii. Training session with Mr Philip Koh on “Duties of Corporate Directors and Senior Management Officers” iii. International Social Wellbeing Conference (ISWC 2024) iv. South East Asia Investments Forum v. IHH Quality Summit vi. Khazanah Megatrends Forum 2024 vii. The Singapore International Agri-Food Week (SIAW) Mok Jia Mei (Alternate Director to Lim Tsin-Lin) i. 42nd Annual J.P. Morgan Healthcare Conference ii. Kincentric Insights Lab 1: Cultivating Culture that drive Business Performance iii. Kincentric Insights Lab 2: Sustainable Succession and Talent Ecosystem iv. Responsible Investment in Practice programme by PRI Academy v. The Future of Cybersecurity with AI The Board is satisfied that the training programmes attended by the Directors in 2024 were comprehensive, relevant and instrumental in enabling the Directors to effectively fulfil their responsibilities. During the financial year under review and as part of the BDEE, the Directors undertook an assessment of their individual development areas. The Directors were encouraged to participate in pertinent training programmes to further enhance their capabilities in discharging their duties and responsibilities. 3. Remuneration As the Company continues to grow, we are committed to providing appropriate remuneration for our talents by aligning pay and performance with the key strategic drivers of our long-term growth. Our policy on Directors’ remuneration aims to attract, retain and motivate capable Directors to manage the Group successfully. The remuneration is carefully aligned with industry practices, considering the calibre of each Director, while upholding the interests of our shareholders. The Senior Management’s (including Executive Directors, if any) remuneration package is designed to link rewards to both corporate and individual performance. The NRC is responsible for reviewing and recommending to the Board the policy and framework for Directors’ remuneration and the remuneration package for our Senior Management, where applicable. In the process, the NRC may seek advice from external consultants for the recommendation of the Group’s remuneration policy. The Board holds the ultimate responsibility for approving the GCEO’s remuneration and the GCEO does not participate in discussions or decisions regarding his own remuneration. As per the Board Charter of the Company, a formal independent review of the NonExecutive Directors’ (NEDs) remuneration is to be undertaken no less frequently than once every three years. The last independent review was performed in 2022 by Korn Ferry. The objective is to ensure that the remuneration and benefits of the NEDs are competitive, appropriate and aligned with prevalent market practices. Our Directors’ remuneration framework aims to attract, retain and motivate capable Directors to manage the Company successfully. The NEDs’ remuneration framework reflects the merits, valuable contributions and level of responsibilities they undertake. The Board determines the fees payable to NEDs, with individual Directors abstaining from decisions regarding their own remuneration packages. All Board members are eligible for medical benefits and are covered by Directors and Officers liability insurance for any liabilities incurred in the discharge of their duties, provided they have not acted fraudulently or dishonestly or derived any personal profit or advantage.
RkJQdWJsaXNoZXIy NDgzMzc=